,drug,MOAs
59,CN(C)c1ccc(C=C2C(=O)Nc3ccccc32)cc1,PDGFR tyrosine kinase receptor inhibitor|tyrosine kinase inhibitor|VEGFR inhibitor
64,O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1,Aurora kinase inhibitor
36,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,serotonin receptor agonist
20,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,polar auxin transport inhibitor
60,COC(=O)Nc1nc2ccc(S(=O)c3ccccc3)cc2[nH]1,anthelmintic agent
57,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
84,CS(=O)CCCCN=C=S,anticancer agent|aryl hydrocarbon receptor antagonist
106,NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O,nedd activating enzyme inhibitor
122,COc1ccc2[nH]c(C(=O)c3ccccc3)cc2c1,microtubule inhibitor
77,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,DNA replication inhibitor|STAT inhibitor
207,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|src inhibitor
133,O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1,ATM kinase inhibitor|ATR kinase inhibitor
6,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,HIV protease inhibitor
56,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)[nH]n1,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor
79,O=[N+]([O-])O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@H]12,nitric oxide stimulant
118,CN1CCN2c3ncccc3Cc3ccccc3C2C1,adrenergic receptor antagonist|serotonin receptor antagonist
71,O=C1C(SCCO)=C(SCCO)C(=O)c2ccccc21,CDC inhibitor
47,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,MEK inhibitor
143,Cc1nc(=O)c2cc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)ccc2[nH]1,thymidylate synthase inhibitor
2,COc1ccc(-n2c(SCc3nc(-c4ccc(C)cc4)no3)nnc2-c2ccncc2)cc1,None
3,CCC(C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](CC=C(C)[C@@H](OC3C[C@H](OC)C(O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)C=CC=C3CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,benzodiazepine receptor agonist
103,C=CCc1cccc(C=NNC(=O)CN2CCN(Cc3ccccc3)CC2)c1O,caspase activator
11,Cn1cnc([N+](=O)[O-])c1Sc1[nH]cnc2ncnc1-2,dehydrogenase inhibitor
166,CC[C@@H](C(=O)C(C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(=O)O)C1OC(CC)(C2CC[C@](O)(CC)[C@H](C)O2)C[C@@H]1C,bacterial permeability inducer
50,O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
7,COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F,phosphodiesterase inhibitor
40,Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1,glycogen synthase kinase inhibitor
131,O=C(Oc1cccc2cccnc12)c1ccccc1,antiinfective drug
21,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,dopamine receptor antagonist|serotonin receptor antagonist
135,C[C@]12CCC3c4ccc(O)cc4CCC3C1CCC2=O,estrogen receptor agonist|estrogenic hormone
104,C#C[C@]1(O)CCC2C3CCC4=Cc5oncc5C[C@]4(C)C3CC[C@@]21C,estrogen receptor antagonist|progesterone receptor agonist
88,CC1CC(C)C(=O)C(C(O)CC2CC(=O)NC(=O)C2)C1,protein synthesis inhibitor
76,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,adrenergic receptor agonist
181,CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,pyruvate ferredoxin oxidoreductase inhibitor
61,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C,glucocorticoid receptor antagonist|progesterone receptor antagonist
149,Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1,orexin receptor antagonist
172,O=C(C=Cc1ccc(O)cc1)c1ccc(O)cc1O,guanylate cyclase activator
70,C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1,WEE1 kinase inhibitor
203,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,dihydrofolate reductase inhibitor
170,COc1ccc(C2CC(c3c(O)cc(C)oc3=O)=NCCS2)c(OC)c1,P selectin inhibitor
169,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|src inhibitor|tyrosine kinase inhibitor
174,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor
179,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist
53,Nc1nc2ccc(OC(F)(F)F)cc2s1,glutamate inhibitor
100,COCC(=O)NCC=Cc1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,EGFR inhibitor|protein tyrosine kinase inhibitor
99,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,T-type calcium channel blocker
48,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,VEGFR inhibitor
177,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,glucocorticoid receptor agonist
184,Nc1c2c(nc3ccccc13)CCCC2,acetylcholinesterase inhibitor
112,Cc1cnc(C(=O)O)c[n+]1[O-],cholesterol inhibitor
148,Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1,bacterial antifolate
163,COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,sodium channel blocker
156,COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)C=C(C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)NC(=CC1=O)C2=O,HSP inhibitor
199,CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1,GK0582 inhibitor
8,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,dopamine receptor antagonist
27,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,EGFR inhibitor
194,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,Bcr-Abl kinase inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor
162,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,RNA synthesis inhibitor|topoisomerase inhibitor
62,CC(=Cc1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C,retinoid receptor agonist
111,C/C=C/C[C@@H](C)[C@@H](O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)N[C@H](C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,calcineurin inhibitor
208,CC1=CC(=O)c2ccccc2C1=O,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor
69,c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1,smoothened receptor agonist
117,Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,sphingosine kinase inhibitor
25,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,bacterial DNA gyrase inhibitor
44,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,SYK inhibitor
145,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor
22,Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor
130,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor
115,CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,ion channel antagonist
92,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C1C2=O,bacterial 30S ribosomal subunit inhibitor
73,O=C(C=Cc1ccccc1)NC(NC(=S)Nc1cccc2cccnc12)C(Cl)(Cl)Cl,eukaryotic translation initiation factor inhibitor
195,Cc1cc(CCc2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1,androgen receptor antagonist
125,CC1(C)C2CC[C@]3(C)C(C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@]43C)[C@@]2(C)CC[C@@H]1OC(=O)CCC(=O)O,11-beta hydroxysteroid dehydrogenase inhibitor
68,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C1C,mTOR inhibitor
67,C#C[C@]1(O)CCC2C3CCC4=CC(=O)CC[C@@H]4C3CC[C@@]21C,progesterone receptor agonist
23,C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,adenylyl cyclase activator
39,CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1,estrogen receptor antagonist
205,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,opioid receptor agonist
120,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|src inhibitor
168,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor
107,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,lanosterol demethylase inhibitor|sterol demethylase inhibitor
102,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,cytochrome P450 inhibitor|imidazoline receptor ligand
91,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,IKK inhibitor
132,CC(C=CC=C(C)/C=C/C1=C(C)CCCC1(C)C)=CC(=O)O,retinoid receptor agonist|retinoid receptor ligand
173,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,tumor necrosis factor production inhibitor
128,COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,MDM inhibitor
42,C[C@@H]1CC[C@H]2[C@@H](C)C(OC(=O)CCC(=O)O)OC3O[C@]4(C)CC[C@@H]1[C@]32OO4,DNA synthesis inhibitor
81,CNCCC=C1c2ccccc2CCc2ccccc21,tricyclic antidepressant
82,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2C1=NO,glycogen synthase kinase inhibitor|lipoxygenase inhibitor
33,OCCn1cc(-c2ccc3c(c2)CCC3=NO)c(-c2ccncc2)n1,RAF inhibitor
96,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,sodium/potassium/chloride transporter inhibitor
49,CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1,BCL inhibitor
26,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,CDK inhibitor
54,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,p38 MAPK inhibitor
129,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,serotonin receptor agonist|serotonin receptor antagonist
18,Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12,adenosine receptor antagonist
121,CN(CC[C@@H](Oc1ccc(-c2ccccc2)cc1)c1ccc(F)cc1)CC(=O)O,Glycine transporter 1 inhibitor
52,COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C,ATPase inhibitor|gastrin inhibitor
15,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,insulin sensitizer|PPAR receptor agonist
83,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator
